Pharmaceutical Packaging Market worth $269.9 billion by 2028 – At a CAGR of 15.4%

As per the recently published report by MarketsandMarkets™, The Pharmaceutical Packaging Market by Raw Material (Plastic, Paper & Paperboard, Glass, Metal), Type (Plastic Bottles, Blisters, Caps & Closures, Labels & Accessories, Pre-filled Syringes), Drug Delivery, and Region – Global Forecast to 2028″, is approximated to be USD 132.0 billion in 2023, and it is projected to reach USD 269.9 billion by 2028, at a CAGR of 15.4%.  The market growth is driven by growing healthcare expenditure and the pharmaceutical industry in emerging economies. The growing demand for drug delivery devices and blister packaging also plays a pivotal role in propelling the pharmaceutical packaging market.

Download PDF Brochure:
  • 280 Market data Tables
  • 45 Figures
  • 290 Pages and in-depth TOC on “Pharmaceutical Packaging Market – Global Forecast to 2028”
This report also provides a comprehensive analysis of the companies listed below:

The key players in the pharmaceutical packaging market include Berry Global Group, Inc. (US), Gerresheimer AG (Germany), Amcor Plc (Switzerland), Schott AG (Germany), and AptarGroup, Inc. (US) and others. The growing trend of rising consumer awareness for safe and secure packaging solutions is driving the market. These players have adopted various strategies such as mergers & acquisitions, joint ventures, and expansion to strengthen their market position.

Recent Developments in Pharmaceutical Packaging Market Industry
  1. In June 2022, Becton, Dickinson and Company acquired Parata Systems. This strategic acquisition enables the company to venture into new pharmacy automation solutions aimed at reducing costs, enhancing patient safety, and improving the overall patient experience. It bolsters the company’s pharmacy automation portfolio by incorporating high-speed robotic dispensing technologies, medication adherence packaging, and pharmacy workflow solutions.
  2. In November 2022, Amcor investment in PulPac fiber technology, a Swedish company providing disruptive manufacturing technology for low-cost, high-performance fiber-based packaging.
  3. In November 2022, Aptar Pharma collaborated with TFF Pharmaceuticals. The collaboration focuses on the development and testing of dry powder vaccines administration using TFF Pharmaceutical’s Thin Film Freezing technology and Aptar Pharma’s proprietary intranasal Unidose (UDS) powder nasal spray system.

Leave a Comment

Your email address will not be published. Required fields are marked *